ESR Project 4
Nancy Deianova was born in 1994 in Belgium. In 2018, she graduated as a medical doctor at Ghent University. During her medical clerkship, she gained international experience in Germany, Brazil, Bulgaria and Belgium. In 2019, she was enrolled as an early stage researcher within the GROWTH-consortium.
Working within this consortium, employed by the Amsterdam University Medical Center (UMC), she will be analyzing the correlation between early development of bacteria in the gut and health later in life. In this study, conducted in a cohort exclusively consisting of very and extremely preterm infants, the team will evaluate how early life diseases (like necrotizing enterocolitis and late onset sepsis) and duration of antibiotic exposure impact early colonization and long-term health. Their aim is to provide insight in the pathogenesis of invalidating non-communicable diseases (e.g. asthma, allergies and IBD), and consequently contribute to the development of decision models and microbiome-targeted therapeutics.
For this project, the pediatric gastroenterology department of Amsterdam UMC will be collaborating with 9 Dutch and Belgian neonatal intensive care units and national and international microbial laboratories.